MAPT and Alzheimer disease: Caspase-dependent GSDMD acts as the executive protein of pyroptosis, and inflammasome, Aβ, Tau protein, pro-inflammatory cytokines and other molecules related to the pathogenesis of AD are involved in its upstream implying the targeting on pyroptosis can be the next therapeutic target for alleviating AD pathology.